Enhertu Side Effects: Common, Mild, and Serious

Medical note: This article is for educational purposes only and should not replace advice from an oncology team. Enhertu can cause serious side effects, and any new, worsening, or unusual symptom should be reported to a healthcare professional promptly.

Enhertu sounds almost gentle, like the name of a spa lotion or a very optimistic houseplant. In reality, Enhertu is a powerful cancer medicine with a serious job: helping treat certain HER2-related cancers when a doctor decides it is the right option. Its generic name is fam-trastuzumab deruxtecan-nxki, and it belongs to a class of medicines called antibody-drug conjugates. Think of it as a targeted delivery system: one part helps find cancer cells with HER2 activity, while another part delivers a chemotherapy-like payload.

That targeted design is one reason Enhertu has become an important treatment in breast cancer and several other HER2-expressing cancers. But “targeted” does not mean “side-effect free.” Enhertu can affect the digestive system, blood counts, hair, energy levels, lungs, heart, liver tests, and more. Some side effects are common and manageable. Others are rare but serious enough that they deserve bold letters, flashing lights, and zero “let’s wait until Monday” energy.

This guide explains Enhertu side effects in plain English: the common ones, the mild ones, the serious ones, what symptoms may feel like in real life, and when to call the care team. No panic. No sugarcoating. Just useful information with a little humor because cancer treatment already has enough gloomy wallpaper.

What Is Enhertu?

Enhertu is a prescription cancer treatment given by intravenous infusion. It is used for certain cancers that involve HER2, including some breast cancers, gastric or gastroesophageal junction cancers, non-small cell lung cancers, and other solid tumors when specific testing shows the medicine may be appropriate. The exact use depends on cancer type, HER2 status, previous treatments, and the oncologist’s treatment plan.

The medicine combines a HER2-directed antibody with a topoisomerase inhibitor payload. In simpler words, one part helps the drug attach to cancer cells with HER2 expression, and the other part interferes with cancer cell growth. This approach can be effective, but it can also affect healthy cells, especially fast-changing cells such as blood cells and cells in the digestive tract.

Why Enhertu Side Effects Happen

Side effects happen because cancer medicines do not work in a vacuum. Enhertu travels through the bloodstream, interacts with cells, and can trigger changes in normal body systems. Some reactions are related to the chemotherapy-like part of the drug. Others are related to immune or inflammatory responses, blood count changes, or effects on specific organs such as the lungs or heart.

Not everyone has the same experience. One person may feel mostly tired and mildly nauseated. Another may have constipation, hair thinning, and low blood counts. A third may need treatment paused because of lung inflammation. Your age, cancer type, dose, previous treatments, other health conditions, and current medications can all influence how Enhertu feels in your body.

Common Enhertu Side Effects

The most common side effects of Enhertu often involve the stomach, energy level, blood counts, hair, appetite, and bowel habits. These effects can range from barely noticeable to “my body has filed a complaint with management.”

Nausea and Vomiting

Nausea is one of the best-known Enhertu side effects. It may show up soon after treatment or later, and for some people it can be stubborn. Vomiting may also occur. The good news is that oncology teams often prescribe anti-nausea medicines before or after treatment to help prevent symptoms instead of chasing them after they arrive.

Practical examples include eating smaller meals, choosing bland foods during queasy days, sipping fluids slowly, and avoiding strong smells. If the smell of a favorite food suddenly makes you want to negotiate with your stomach, that does not mean the food betrayed you forever. It may just be a treatment-day thing.

Fatigue

Fatigue from Enhertu is not the same as ordinary sleepiness. It can feel like your battery charged to 22% overnight and refuses to go higher. Some people can still work, walk, cook, or run errands. Others need to redesign their day around rest, shorter tasks, and strategic couch positioning.

Fatigue may be linked to the medicine itself, anemia, poor appetite, sleep problems, emotional stress, dehydration, or the cancer. Gentle movement, hydration, balanced meals, and planned rest may help, but severe or sudden fatigue should be discussed with the care team.

Low White Blood Cell Counts

Enhertu can lower white blood cells, including neutrophils. These cells help fight infection. When counts drop too low, the body may have a harder time handling bacteria, viruses, or other germs. This is why routine blood tests are not just medical decoration. They are part of the safety system.

Symptoms that may suggest infection include fever, chills, sore throat, cough, burning during urination, unusual tiredness, or a wound that is not healing. A fever during cancer treatment should be taken seriously. Do not try to “tough it out” like a movie hero with questionable decision-making skills.

Anemia

Anemia means the body has fewer red blood cells than normal. Red blood cells carry oxygen, so anemia can cause tiredness, shortness of breath with activity, dizziness, pale skin, headaches, or a racing heartbeat. Mild anemia may simply be monitored. More significant anemia may require treatment changes, supportive care, or additional evaluation.

Low Platelet Counts

Platelets help blood clot. If Enhertu lowers platelet counts, bruising or bleeding may become easier. Watch for frequent nosebleeds, bleeding gums, unusual bruises, tiny red or purple spots on the skin, blood in urine or stool, or bleeding that takes longer than usual to stop.

Hair Loss or Hair Thinning

Hair loss with Enhertu can vary. Some people notice thinning rather than complete loss, while others experience more obvious shedding. Hair changes can be emotionally difficult because they are visible and personal. It is okay to care about this. Wanting to feel like yourself during treatment is not vanity; it is human.

Constipation

Constipation may happen from Enhertu, anti-nausea medicines, reduced activity, dehydration, or changes in eating patterns. It can feel uncomfortable and can quickly become the side effect nobody wanted to discuss but everyone wants fixed. Fluids, fiber, movement, and prescribed stool softeners or laxatives may help, but patients should follow their care team’s instructions.

Diarrhea

Some people go in the opposite direction and experience diarrhea. This can lead to dehydration, weakness, irritation, and electrolyte problems if it becomes severe. Call the care team if diarrhea is persistent, severe, bloody, or accompanied by dizziness, fever, or inability to keep fluids down.

Decreased Appetite

Enhertu can make food less appealing. Taste changes, nausea, mouth irritation, fatigue, and stress can all pile on. When appetite drops, small high-protein meals or snacks may be easier than three full meals. Smoothies, soups, eggs, yogurt, nut butters, soft foods, or nutrition drinks may be useful depending on what the patient can tolerate.

Increased Liver Function Tests

Enhertu may cause changes in liver blood tests, sometimes called increased transaminases. Many people do not feel symptoms from mild lab changes, which is why scheduled blood work matters. If liver irritation becomes more significant, a doctor may adjust treatment or investigate other causes.

Low Potassium

Low potassium, also called hypokalemia, can occur. Potassium is important for muscles, nerves, and heart rhythm. Symptoms may include weakness, cramps, constipation, or heart palpitations, although mild cases may only show up on lab tests. Treatment may include diet changes or supplements if the oncology team recommends them.

Muscle, Bone, or Joint Pain

Some people report musculoskeletal pain, including muscle aches, bone pain, joint discomfort, back pain, or pain in the arms or legs. This may be mild and temporary, but persistent pain deserves attention, especially in cancer care where pain can have many possible causes.

Mild Enhertu Side Effects

Mild side effects are symptoms that are uncomfortable but not immediately dangerous. However, “mild” does not mean “ignore forever.” A small issue can become a bigger one if it affects eating, drinking, sleep, movement, or infection risk.

Examples of Mild Side Effects

Mild Enhertu side effects may include mild nausea, occasional vomiting, constipation, diarrhea, reduced appetite, hair thinning, dry eyes, headache, dizziness, mild cough, taste changes, mouth irritation, skin color changes, or mild body aches. These symptoms should still be reported at appointments, especially if they are new or changing.

A useful rule: if a side effect disrupts daily life, lasts longer than expected, or makes the patient wonder “Is this normal?” it is worth mentioning. Oncology nurses have heard almost everything. You will not shock them by asking about bowel habits, taste changes, or whether your eyebrows are staging a slow exit.

Serious Enhertu Side Effects

Enhertu can cause serious side effects that need fast medical attention. The most important ones involve the lungs, pregnancy risk, severe infection, low blood counts, heart function, infusion reactions, and severe digestive or electrolyte problems.

Lung Problems: Interstitial Lung Disease and Pneumonitis

The most important serious risk with Enhertu is interstitial lung disease, also called ILD, and pneumonitis. This means inflammation or damage in the lungs. In some cases, it can be life-threatening or fatal. This risk is serious enough that Enhertu carries a boxed warning.

Symptoms may include a new or worsening cough, shortness of breath, trouble breathing, fever, chest tightness, wheezing, or any new breathing change. The tricky part is that early lung symptoms may seem small. A mild cough may not feel dramatic, but during Enhertu treatment it should never be brushed off casually.

Patients should contact their oncology team immediately if breathing symptoms appear. Doctors may pause treatment, order scans, check oxygen levels, prescribe corticosteroids, or permanently stop Enhertu depending on severity. This is one side effect where early reporting can make a major difference.

Severe Low White Blood Cell Counts and Infection

Low neutrophils can become serious if they lead to infection or fever. Fever with low white blood cells is a medical concern because the body may not be able to fight infection normally. Symptoms that need urgent attention include fever, chills, shaking, sore throat, cough, shortness of breath, painful urination, confusion, or feeling suddenly very unwell.

Heart Problems

Enhertu may affect heart function in some people. Doctors may check heart function before and during treatment, especially in patients with a history of heart disease or previous HER2-directed therapy. Symptoms that may suggest heart problems include shortness of breath, swelling in the ankles or legs, sudden weight gain, chest discomfort, irregular heartbeat, dizziness, or unusual fatigue.

Infusion-Related Reactions

Because Enhertu is given by IV infusion, reactions can happen during or after treatment. Symptoms may include fever, chills, flushing, rash, itching, dizziness, trouble breathing, swelling of the face or throat, or fast heartbeat. Infusion centers monitor patients carefully, especially during early treatments. If something feels wrong during an infusion, speak up immediately. This is not the time to be polite and silently suffer.

Pregnancy-Related Harm

Enhertu can harm an unborn baby. Patients who can become pregnant may need pregnancy testing before treatment and effective birth control during treatment and for a period after the last dose. Male patients with partners who can become pregnant may also be advised to use contraception for a period after treatment. Anyone who is pregnant, planning pregnancy, or breastfeeding should discuss this with the oncology team before treatment.

Severe Vomiting, Diarrhea, or Dehydration

Vomiting or diarrhea can become serious if the patient cannot keep fluids down, becomes dizzy, urinates very little, feels weak, or has signs of dehydration. Severe diarrhea may also affect electrolytes such as potassium or magnesium. The care team may prescribe medicines, fluids, electrolyte replacement, or treatment delays if needed.

When to Call a Doctor Immediately

Call the oncology team right away for new or worsening cough, shortness of breath, fever, chest tightness, wheezing, chills, signs of infection, severe vomiting, severe diarrhea, unusual bleeding, black or bloody stool, severe weakness, fainting, chest pain, swelling of the legs, fast or irregular heartbeat, confusion, or allergic-type symptoms such as swelling, hives, or trouble breathing.

When in doubt, call. Cancer teams would much rather answer a cautious question than hear later that a serious symptom was ignored. “I did not want to bother anyone” is understandable, but it is not a safety strategy.

How Doctors Monitor Enhertu Side Effects

Monitoring usually includes regular blood tests, symptom checks, medication reviews, and sometimes heart tests or imaging. Blood tests can track white blood cells, red blood cells, platelets, liver enzymes, kidney function, and electrolytes. Imaging may be used if lung symptoms appear or if the oncologist is watching for treatment response.

Patients should keep a simple symptom diary. It does not need to be fancy. A notebook, phone note, or calendar can work. Track symptoms, when they started, what made them better or worse, temperature readings, bowel changes, appetite, and medicines taken. This gives the care team clearer information than “I felt weird last Thursday-ish.”

Tips for Managing Common Enhertu Side Effects

For Nausea

Take anti-nausea medicine exactly as prescribed. Eat small meals, avoid greasy foods when queasy, try bland snacks, and sip fluids throughout the day. Ginger, crackers, toast, rice, applesauce, bananas, and soups may help some people, though every stomach has its own dramatic personality.

For Fatigue

Plan activities around energy peaks. Accept help with errands or chores when possible. Gentle walking or stretching may help some patients, but rest is also part of treatment. Fatigue that is sudden, severe, or linked with dizziness or shortness of breath should be reported.

For Low Blood Counts

Wash hands often, avoid close contact with sick people, follow food safety instructions, and report fever quickly. For low platelets, avoid injury when possible and ask the care team before using medicines that may increase bleeding risk.

For Constipation or Diarrhea

Ask the care team which over-the-counter options are safe. Do not assume every laxative or anti-diarrheal medicine is appropriate. Hydration matters, and persistent bowel changes should be reported before they become a full gastrointestinal soap opera.

Questions Patients Can Ask Their Oncology Team

Good questions include: Which side effects are most likely for me? What symptoms should make me call immediately? What temperature counts as a fever emergency? Should I take anti-nausea medicine before symptoms start? How often will my blood counts be checked? Will I need heart monitoring? What should I do if I develop a cough? Are there foods, supplements, or medicines I should avoid?

Patients may also ask who to call after hours. Side effects rarely check the office schedule before appearing. Having the emergency number saved in a phone can reduce stress when decisions need to happen quickly.

Real-World Experiences and Practical Reflections on Enhertu Side Effects

People taking Enhertu often describe the experience as a balance between hope and homework. The hope comes from receiving a treatment designed for HER2-related cancer. The homework comes from managing symptoms, tracking labs, attending infusions, and learning which body signals matter most.

One common experience is learning that nausea can be more predictable than expected. Some patients notice a pattern: queasiness on infusion day, a harder second or third day, then gradual improvement. Others feel fine at first and then get delayed nausea. This is why a written plan for anti-nausea medicine can be so helpful. Patients sometimes wait too long to take medication because they want to “see if it gets bad.” Unfortunately, nausea is easier to prevent than to wrestle after it has put on boxing gloves.

Fatigue can also reshape routines. A person who usually handles work, family tasks, errands, and appointments may suddenly need to prioritize like a project manager with a very limited energy budget. Many patients find it helpful to divide tasks into “must do,” “nice to do,” and “absolutely not today.” Laundry may move from urgent to optional. Rest may move from optional to medically sensible. That is not laziness; that is treatment strategy.

Food experiences can become strangely personal. A favorite meal may taste metallic, bland, too sweet, or suddenly unacceptable. Some patients rely on simple foods for a while: oatmeal, eggs, rice, toast, soup, yogurt, smoothies, or whatever does not start a rebellion in the stomach. Caregivers can help by offering choices instead of pressure. “Would soup or toast be easier?” usually lands better than “You have to eat more,” even when the concern comes from love.

Hair thinning is another side effect that may carry more emotional weight than outsiders expect. It can be frustrating to hear “at least it is only hair” when hair is tied to identity, privacy, and control. Some people choose scarves, wigs, hats, shorter haircuts, or no cover at all. There is no correct style of bravery. Looking like yourself, or choosing a new look that feels comfortable, can be part of emotional self-care.

The lung-risk conversation can feel scary, but it can also be empowering. Patients who understand the warning signs are better prepared to act early. A new cough, shortness of breath, fever, or chest tightness should not be filed under “probably nothing” during Enhertu treatment. Calling quickly does not mean assuming the worst; it means giving the team a chance to check before a small problem becomes larger.

Many patients also discover that communication is a side-effect management tool. The best appointment notes often include specifics: “I vomited twice on day two,” “I had diarrhea four times in 24 hours,” “I felt short of breath walking upstairs,” or “My temperature was 100.6°F.” Specific details help clinicians decide whether to adjust supportive medicines, order tests, delay treatment, reduce the dose, or investigate serious complications.

Caregivers may have their own experience, too. They may notice appetite changes, fatigue, mood shifts, or breathing changes before the patient does. A helpful caregiver does not need to become a detective with a magnifying glass, but gentle observation can be valuable. The goal is support, not surveillance. Cancer treatment is already enough of a group project.

Perhaps the most important real-world lesson is that side effects are not a personal failure. Needing anti-nausea medicine, fluids, rest, blood tests, treatment delays, or dose adjustments does not mean someone is weak. It means the body is responding to a strong therapy. The goal is not to “win” by pretending everything is fine. The goal is to stay safe, communicate clearly, and help the oncology team keep treatment as effective and tolerable as possible.

Conclusion

Enhertu can be an important treatment option for certain HER2-related cancers, but it comes with a wide range of possible side effects. Common Enhertu side effects include nausea, vomiting, fatigue, hair thinning, constipation, diarrhea, decreased appetite, low blood counts, liver test changes, and muscle or bone pain. Many of these can be managed with supportive care, medication, monitoring, and honest communication with the oncology team.

The serious risks deserve special attention. Lung problems such as interstitial lung disease or pneumonitis can be life-threatening and should be reported immediately if symptoms appear. Fever, infection signs, severe weakness, unusual bleeding, heart symptoms, infusion reactions, severe vomiting, or severe diarrhea also require prompt medical guidance.

The best approach is not fear; it is awareness. Know the likely side effects, track symptoms, keep appointments, ask practical questions, and call the care team early when something changes. Enhertu may be powerful medicine, but patients do not have to navigate its side effects with guesswork and crossed fingers.